KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Intangibles (2016 - 2025)

Elevance Health (ELV) has disclosed Intangibles for 17 consecutive years, with $11.3 billion as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles rose 9.7% to $11.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $11.3 billion, a 9.7% increase, with the full-year FY2024 number at $12.1 billion, up 17.73% from a year prior.
  • Intangibles was $11.3 billion for Q3 2025 at Elevance Health, down from $11.5 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $12.1 billion in Q4 2024 to a low of $9.4 billion in Q1 2021.
  • A 5-year average of $10.8 billion and a median of $10.7 billion in 2021 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: dropped 2.83% in 2022, then rose 17.73% in 2024.
  • Elevance Health's Intangibles stood at $10.6 billion in 2021, then dropped by 2.83% to $10.3 billion in 2022, then fell by 0.41% to $10.3 billion in 2023, then grew by 17.73% to $12.1 billion in 2024, then fell by 6.34% to $11.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Intangibles are $11.3 billion (Q3 2025), $11.5 billion (Q2 2025), and $11.9 billion (Q1 2025).